RADNOR, PA / ACCESSWIRE / February 19, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against iRhythm Technologies, Inc. (NASDAQ:IRTC) ("iRhythm") on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the "Class Period").
LOS ANGELES, Feb. 19, 2021 (GLOBE NEWSWIRE) The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of.
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of iRhythm Technologies, Inc. ("iRhythm" or the "Company") (NASDAQ: IRTC) from August 4, 2020 and January 28, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934. If you purchased iRhythm securities, and/or would like to discuss your legal rights and options please visit iRhythm Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors that: (1) iRhythm's business would
The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against iRhythm Technologies, Inc. (NASDAQ: IRTC) ("iRhythm") on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the "Class Period").
Key Developments in the Market:
In September 2018, Otsuka and Magellan Health together have launched their first digital pill AbilfyMyCite, to treat mental health disorders. It has a Proteus Digital Health sensor embedded in the tablet, wherein all the information is linked and downloaded on a Bluetooth enabled device
In December 2018, ResMed, a world leading health company in cloud-connected medical devices acquired Propeller Health, a digital therapeutics company that deals the medication problems of people suffering with COPD and asthma. Propellers digital medicines consists of small sensors which are attached to the inhaler pumps of consumers and linked with a mobile app to automatically track medication use and provide immediate response and generate feedback